Health System

The removal of the boxed warning from canagliflozin was based on the FDA’s review of new data from 3 clinical trials.

Amisuplride injection (Barhemsys; Acacia) is the first and only antiemetic to be approved for the rescue treatment of PONV in patients who have failed prior prophylaxis with an agent of a different class.

An examination of how telehealth services for medically underserved patients in rural areas improve access to pharmacists for chronic care management.

Here's this week's coronavirus-related news that you should know.

Results of the study demonstrated conclusive evidence of drug dose gender gaps from 86 different FDA-approved medications.

Two senior administration officials from Operation Warp Speed offered the latest updates on COVID-19 vaccine development.

Here's the coronavirus-related news from this week that you should know.

The COVID-19 crisis poses unique challenges for managing controlled substances in hospitals.

The opioid’s indication was based on several randomized controlled trials, where patients reported decreased pain.

Here's this week's coronavirus-related news you should know.

The grants are part of the administration’s continuing focus on rural health initiatives.

ESMO released changes to its recommendations on how to manage patients with cancer during the COVID-19 pandemic.

The FDA approved a cannabidiol oral solution treatment (Epidiolex, Greenwich Biosciences) for seizures associated with tuberous sclerosis complex.

The state joins New York and Minnesota in providing COVID-19 vaccination access through pharmacy.

A panel has given a “weak recommendation” for the use of remdesivir in patients with severe coronavirus disease 2019.

Joshua Miller, MD MPH and medical director of diabetes care for Stony Brook Medicine, discusses continuous glucose monitoring (CGM) technology, which the FDA has authorized for use in hospitals amid the COVID-19 pandemic.

Here's this week's coronavirus-related news.

The American Society of Health-System Pharmacists (ASHP) announced plans to hold the 2020 Midyear Clinical Meeting in December as an all-virtual experience.

NACDS, APhA, NCPA, and others warn that overlooking DIR fee reform will be detrimental to pharmacy viability.

Experts will examine the prospects of several COVID-19 vaccine candidates that are entering phase 3 trials.

Here's this week's roundup of the coronavirus-related news you should know.

By adding an adjuvant to an existing vaccine treatment, it’s possible to optimize the body’s response to the presence of a virus.

An inside look at the process from prescription to dispensing.

In a letter to President Trump, NCPA CEO explained that failure to implement sweeping DIR fee reform would be detrimental to independent community pharmacies and their patients.

On May 8, 2020, the FDA granted accelerated approval to selpercatinib (Retevmo; Eli Lilly and Company).

Here's the coronavirus-related news you should know from this week.

A recent study found that the programs may result in cost savings to health systems and patients.

Enhanced pharmacy services such as home delivery, curbside services, and expanded personal patient outreach create opportunities to address social determinants of health during the pandemic.

In part 2 of our interview, Dr. Cheryl Wisseh, PharmD, MPH, zone 5 director, NPhA, dives into the forces that bring about racial disparities, and offers pharmacy and health system-centered solutions.

Sandoz is collaborating with Civica Rx to provide critical injectable generic medicines to hospitals to help reduce supply shortages.